40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details

臨床試験数 : 24 / 薬物数 : 40 - (DrugBank : 18) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 110

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2061210007	13/10/2021	28/05/2021	A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Usteki ...	Takayasu Arteritis	Ustekinumab Participants will receive IV infusion and SC injection of ustekinumab. Placebo Participants ...	Nishikawa Kazuko	NULL	Recruiting	>= 18age old	<= 75age old	Both	50	Phase 3	Japan
2	NCT04882072 (ClinicalTrials.gov)	September 15, 2021	10/5/2021	A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Usteki ...	Takayasu Arteritis	Drug: Ustekinumab;Other: Placebo;Drug: Glucorticoid Taper Regimen	Janssen Pharmaceutical K.K.	NULL	Active, not recruiting	15 Years	75 Years	All	14	Phase 3	Japan

First Previous1Next Last